[Clinical experiences with the new antidepressive agent Maprotilin 34'276 Ba].
D000328:Adult; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011437:Propylamines / Q000009:adverse effects / Q000627:therapeutic use
D000873:Anthracenes; D010919:Placebos; D011437:Propylamines
Klinische Erfahrungen mit dem neuen Antidepressivum Maprotilin 34'276 Ba.